Title: Horley NJ, et al. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines. Eur J Med Chem. 2017 Mar 31;129:159-174.
16232-05-6
18455-64-6
1514888-56-2 | S1p receptor agonist 1 | AA01EOJP | MFCD30738002
443639-96-1 | S119-8 | AA01EOOH | MFCD01121291
1630022-96-6 | [1-(4-hydroxypentyl)-1H-indol-3-yl](4-hydroxyphenyl)-methanone | AA01EOX6
1997286-65-3 | 12-[(1-oxohexadecyl)oxy]-octadecanoicacid | AA01EP75
1914971-16-6 | N-(4,6-dimethyl-2-pyridinyl)-4-(4-pyridinyl)-1-piperazinecarbothioamide | AA01EPFV | MFCD30343877
1253909-57-7 | 2-[(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaen-1-yloxy]-butanoicacid | AA01EPL5
50423-15-9 | 2-methyl-5-(8Z,11Z)-8,11,14-pentadecatrienyl-1,3-benzenediol | AA01EPRX
544-70-7 | 9Z,11Z-octadecadienoicacid | AA01EQ06
3871-89-4 | N-ethyl-2-fluoro-α-methyl-benzeneethanamine,monohydrochloride | AA01EQ7H
1449208-36-9 | EnsembleCompound159 | AA01EQD8